Category: Health regulations

The US Food and Drug Administration (FDA) officially ended the general availability of compounded tirzepatide after March 19, 2025, following the resolution of the national drug shortage. This decision significantly alters the landscape for individuals who previously relied on these versions for managing conditions like type 2 diabetes and obesity. The FDA has shifted its focus to ensuring access through FDA-approved products, primarily Mounjaro and Zepbound, and reinforcing patient safety standards.

In pharmacology and healthcare policy, the term 'exempt prescription' has at least two significantly different meanings depending on the context, often concerning controlled substances in the US or patient payment obligations in the UK. Understanding which regulation is being referenced is crucial for both healthcare providers and patients. This guide will clarify the nuances behind what does exempt prescription mean.